IDEXX Laboratories, Inc. logo
IDEXX Laboratories, Inc. (IDXX)
Compare

IDEXX Laboratories, Inc. (IDXX) Current Ratio: 1.17

Is IDEXX Laboratories, Inc.’s current ratio high or low?

IDEXX Laboratories, Inc.'s current ratio of 1.17 is 12% below its 5-year average of 1.33, around the middle of its 5-year range (0.89–1.82).

The current ratio for IDEXX Laboratories, Inc. (IDXX) is 1.17 as of Tuesday, June 9, 2026. It is below its 12-month average by 5.65% (1.24).

IDXX Current Ratio Chart

IDXX Current Ratio
1.17-10.69% 1Y
Zoom

IDXX Average Current Ratio Chart

IDXX Current vs Average Current Ratio Chart

IDXX Current Ratio Metrics

CURRENT RATIO

1.17

CURRENT RATIO AVG TTM

1.24

CURRENT RATIO AVG 3Y

1.23

CURRENT RATIO AVG 5Y

1.33

CURRENT RATIO AVG 10Y

1.15

CURRENT RATIO AVG 15Y

1.20

CURRENT RATIO AVG 20Y

1.35

CURRENT VS TTM AVG

-5.65%

CURRENT VS 3Y AVG

-5.26%

CURRENT VS 5Y AVG

-12.36%

CURRENT VS 10Y AVG

+1.90%

CURRENT VS 15Y AVG

-2.19%

CURRENT VS 20Y AVG

-13.55%

IDXX Competitors' Current Ratio

NAMEMARKET CAPCURRENT RATIOTTM3Y5Y
IDEXX Laboratories, Inc. (IDXX)1.171.241.231.33
Humana Inc. (HUM)$43.60B0.720.580.570.58
Agilent Technologies, Inc. (A)$38.26B1.962.022.172.21
Zoetis Inc. (ZTS)$34.46B3.032.392.632.90
Centene Corporation (CNC)$32.69B1.681.401.241.19
IQVIA Holdings Inc. (IQV)$31.09B0.750.790.830.90
DexCom, Inc. (DXCM)$30.17B1.881.672.043.15
Biogen Inc. (BIIB)$29.39B2.682.022.252.11
Regeneron Pharmaceuticals, Inc. (REGN)$63.48B4.134.434.904.47
Veeva Systems Inc. (VEEV)$27.37B4.894.704.394.08

Liquidity Analysis

Current Ratio

1.17

Quick Ratio

0.84

IDEXX Laboratories, Inc. Current Ratio Formula & Definition

Current Ratio = Current Assets / Current Liabilities

The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

IDEXX Laboratories, Inc. Current Ratio FAQ

What is the current ratio for IDEXX Laboratories, Inc. (IDXX)?
The current ratio for IDXX stock is 1.17.
Is IDEXX Laboratories, Inc.'s current ratio high or low?
IDEXX Laboratories, Inc.'s current ratio of 1.17 is 12% below its 5-year average of 1.33, around the middle of its 5-year range (0.89–1.82).
What is the TTM average current ratio for IDEXX Laboratories, Inc. (IDXX)?
The TTM average current ratio for IDXX stock is 1.24.
What is the 3Y average current ratio for IDEXX Laboratories, Inc. (IDXX)?
The 3Y average current ratio for IDXX stock is 1.23.
What is the 5Y average current ratio for IDEXX Laboratories, Inc. (IDXX)?
The 5Y average current ratio for IDXX stock is 1.33.
What is the 10Y average current ratio for IDEXX Laboratories, Inc. (IDXX)?
The 10Y average current ratio for IDXX stock is 1.15.
What is the 15Y average current ratio for IDEXX Laboratories, Inc. (IDXX)?
The 15Y average current ratio for IDXX stock is 1.20.
What is the 20Y average current ratio for IDEXX Laboratories, Inc. (IDXX)?
The 20Y average current ratio for IDXX stock is 1.35.

IDEXX Laboratories, Inc. Current Ratio History

DATECURRENT RATIO
2025-12-311.17
2024-12-311.31
2023-12-311.57
2022-12-310.89
2021-12-311.25
2020-12-311.82
2019-12-310.94
2018-12-310.85
2017-12-310.97
2016-12-310.90
2015-12-310.96
2014-12-310.93
2013-12-311.36
2012-12-311.40
2011-12-311.20
2010-12-311.62
2009-12-311.47
2008-12-311.21
2007-12-311.37
2006-12-312.42
2005-12-312.81
2004-12-313.02
2003-12-313.68
2002-12-313.82
2001-12-313.30
2000-12-312.91
1999-12-313.08
1998-12-313.35
1997-12-313.69
1996-12-315.90

About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.

Westbrook, ME
11,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Jonathan J. Mazelsky